Trial Details

UNKNOWN
Basic Information
Clinical ID c660
Identifier NCT02066272
Trial Title Safety of Anti-tumor Necrosis Factor (TNF) Monoclonal Antibodies in Inflammatory Bowel Disease
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Inflammatory Bowel Disease|Ulcerative Colitis|Crohn's Disease|Indeterminate Colitis
Interventions -
Participant Information
Sponsor Maria Sklodowska-Curie National Research Institute of Oncology
City Warsaw
Country/Region Poland
Enrollment Criteria
Sex Requirement ALL
Age Requirement CHILD, ADULT, OLDER_ADULT
Study Design
Study Type OBSERVATIONAL
Phase -
Time Information
Start Date 2025-01-14
Primary Completion Date 2025-12-15
Completion Date 2025-12-16